Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer’s disease

Why Women Have More Alzheimer's Disease Than Men: Gender and Mitochondrial Toxicity of Amyloid-β Peptide

(2017) Jose Viña et al.   JOURNAL OF ALZHEIMERS DISEASE

The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression

(2011) Filippo Caraci et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cytokine polymorphisms and Alzheimer disease: possible associations

(2010) G. Ribizzi et al.   NEUROLOGICAL SCIENCES

TGF-β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

(2009) Filippo Caraci et al.   CNS Neuroscience & Therapeutics

Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets

(2009) Filippo Caraci et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

No replication of genetic association between candidate polymorphisms and Alzheimer's disease

(2009) Emmanuelle Cousin et al.   NEUROBIOLOGY OF AGING

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

(2008) Lars Bertram et al.   NATURE REVIEWS NEUROSCIENCE

TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

(2008) Filippo Caraci et al.   NEUROBIOLOGY OF DISEASE

Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease

(2007) Leonel E. Rojo et al.   ARCHIVES OF MEDICAL RESEARCH